ru 24926 has been researched along with vasoactive intestinal peptide in 2 studies
| Studies (ru 24926) | Trials (ru 24926) | Recent Studies (post-2010) (ru 24926) | Studies (vasoactive intestinal peptide) | Trials (vasoactive intestinal peptide) | Recent Studies (post-2010) (vasoactive intestinal peptide) |
|---|---|---|---|---|---|
| 30 | 0 | 0 | 10,873 | 123 | 1,221 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kelly, E; Nahorski, SR | 1 |
| Bockaert, J; Enjalbert, A | 1 |
2 other study(ies) available for ru 24926 and vasoactive intestinal peptide
| Article | Year |
|---|---|
Specific inhibition of dopamine D-1-mediated cyclic AMP formation by dopamine D-2, muscarinic cholinergic, and opiate receptor stimulation in rat striatal slices.
Topics: 1-Methyl-3-isobutylxanthine; 2-Chloroadenosine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenosine; Alprostadil; Animals; Benzazepines; Carbachol; Cholera Toxin; Corpus Striatum; Cyclic AMP; Isoproterenol; Morphine; Phenethylamines; Rats; Receptors, Cholinergic; Receptors, Dopamine; Receptors, Muscarinic; Receptors, Opioid; Vasoactive Intestinal Peptide | 1986 |
Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary.
Topics: Adenylyl Cyclases; Animals; Binding, Competitive; Cyclic AMP; Dopamine; Female; Kinetics; Male; Phenethylamines; Pituitary Gland, Anterior; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Sulpiride; Vasoactive Intestinal Peptide | 1983 |